HIV risk was found to be higher in women who used an injectable contraceptive called DMPA than those using a similar product called NET-EN, found in a secondary analysis of data from a large HIV prevention trial called VOICE, researchers from the National Institutes of Health-funded Microbicide Trials Network (MTN) reported today at the 21st Conference on Retroviruses and Opportunistic Infections (CROI) in Boston. An unexpected finding in the study was that the ...
via Medindia Health News
More READ 
Lake forest health and fitness http://ift.tt/1f01GlT
No comments:
Post a Comment